The chemopreventive action of bromelain, from pineapple stem (Ananas comosus L.), on colon carcinogenesis is related to antiproliferative and proapoptotic effects

Molecular Nutrition and Food Research

Volumn 58, Issue 3, 2014, Pages 457-465

  Romano, Barbara ^a   Fasolino, Ines ^a   Pagano, Ester ^a   Capasso, Raffaele ^a   Pace, Simona ^a   De Rosa, Giuseppe ^a   Milic, Natasa ^b   Orlando, Pierangelo ^c   Izzo, Angelo A ^a   Borrelli, Francesca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

Bromelain; Cell proliferation; Chemoprevention; Colon cancer; Protease

Indexed keywords

ANTINEOPLASTIC AGENT; BROMELAIN; CASPASE 3; CASPASE 7; REACTIVE OXYGEN METABOLITE; STEM BROMELAIN;

ANANAS; ANIMAL; APOPTOSIS; CELL PROLIFERATION; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; PATHOLOGY; PLANT STEM; TUMOR CELL LINE;

ANANAS; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BROMELAINS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; MICE, INBRED ICR; PLANT STEMS; REACTIVE OXYGEN SPECIES;

EID: 84897619560     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300345     Document Type: Article

References (41)

1. Ferlay, J., Parkin, D. M., Steliarova-Foucher, E., Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 2010, 46, 765-781.
2. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63, 11-30.
3. Markowitz, S. D., Bertagnolli, M. M., Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 2009, 361, 2449-2460.
4. Haq, S., Ali, S., Mohammad, R., Sarkar, F. H., The complexities of epidemiology and prevention of gastrointestinal cancers. Int. J. Mol. Sci. 2012, 13, 12556-12572.
5. Franceschi, S., Wild, C. P., Meeting the global demands of epidemiologic transition. The indispensable role of cancer prevention. Mol. Oncol. 2013, 7, 1-13.
6. Manzano, A., Pérez-Segura, P., Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention? Sci. World J. 2012, 2012, 327-341.
7. Vargas, A. J., Thompson, P. A., Diet and nutrient factors in colorectal cancer risk. Nutr. Clin. Pract. 2012, 27, 613-623.
8. Lakatos, P. L., Kiss, L. S., Miheller, P., Nutritional influences in selected gastrointestinal diseases. Dig. Dis. 2011, 29, 154-165.
9. Vainio, H., Weiderpass, E., Fruit and vegetables in cancer prevention. Nutr. Cancer 2006, 54, 111-142.
10. Riboli, E., Norat, T., Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr. 2003, 78, 559S-569S.
11. Barone, M., Lofano, K., De Tullio, N., Licinio, R. et al., Dietary, endocrine, and metabolic factors in the development of colorectal cancer. J. Gastrointest. Cancer 2012, 43, 13-19.
12. Romagnolo, D. F., Selmin, O. I., Flavonoids and cancer prevention: a review of the evidence. J. Nutr. Gerontol. Geriatr. 2012, 31, 206-238.
13. Gruenwald, J., Brendler, T., Jaenicke, C., PDR for Herbal Medicines, 4th edn, Thomson Healthcare, Montvale, NJ 2007.
14. Blumenthal, M. (Ed.) The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX 1998.
15. Maurer, H. R., Bromelain: biochemistry, pharmacology and medical use. Cell. Mol. Life Sci. 2001, 58, 1234-1245.
16. Bromelain. Monograph. Altern. Med. Rev. 2010, 15, 361-368.
17. Pavan, R., Jain, S., Shraddha Kumar, A., Properties and therapeutic application of bromelain: a review. Biotechnol. Res. Int. 2012, 2012, 976203, doi:10.1155/2012/976203.
18. Hale, L. P., Greer, P. K., Trinh, C. T., Gottfried, M. R., Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin. Immunol. 2005, 116, 135-142.
19. Hale, L. P., Chichlowski, M., Trinh, C. T., Greer, P. K., Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis. Inflamm. Bowel Dis. 2010, 16, 2012-2021.
20. Onken, J. E., Greer, P. K., Calingaert, B., Hale, L. P., Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin. Immunol. 2008, 126, 345-352.
21. Borrelli, F., Capasso, R., Severino, B., Fiorino, F. et al., Inhibitory effects of bromelain, a cysteine protease derived from pineapple stem (Ananas comosus), on intestinal motility in mice. Neurogastroenterol. Motil. 2011, 23, 1, doi: 10.1111/j.1365-2982.2011.01735.x.
22. Aviello, G., Rowland, I., Gill, C. I., Acquaviva, A. M. et al., Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells. J. Cell. Mol. Med. 2010, 14, 2006-2014.
23. Beuth, J., Braun, J. M., Modulation of murine tumor growth and colonization by bromelaine, an extract of the pineapple plant (Ananas comosum L.). In Vivo 2005, 19, 483-485.
24. Báez, R., Lopes, M. T., Salas, C. E., Hernández, M., In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain. Planta Med. 2007, 73, 1377-1383.
25. Rahman, M., Selvarajan, K., Hasan, M. R., Chan, A. P. et al., Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo. Neoplasia 2012, 14, 624-633.
26. Aviello, G., Romano, B., Borrelli, F., Capasso, R. et al., Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J. Mol. Med. (Berl.) 2012, 90, 925-934.
27. Mascolo, N., Mereto, E., Borrelli, F., Orsi, P. et al., Does senna extract promote growth of aberrant crypt foci and malignant tumors in rat colon? Dig. Dis. Sci. 1999, 44, 2226-2230.
28. Izzo, A. A., Aviello, G., Petrosino, S., Orlando, P. et al., Endocannabinoid Research Group. Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J. Mol. Med. (Berl) 2008, 86, 89-98.
29. Boivin, G. P., Washington, K., Yang, K., Ward, J. M. et al., Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003, 124, 762-777.
30. Bhui, K., Tyagi, S., Srivastava, A. K., Singh, M. et al., Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis. Mol. Carcinog. 2012, 51, 231-243.
31. Dhandayuthapani, S., Perez, H. D., Paroulek, A., Chinnakkannu, P. et al., Bromelain-induced apoptosis in GI-101A breast cancer cells. J. Med. Food 2012, 15, 344-349.
32. Amini, A., Ehteda, A., Masoumi Moghaddam, S., Akhter, J. et al., Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21). Onco Targets Ther. 2013, 6, 403-409.
33. Weigelt, B., Downward, J., Genomic determinants of PI3K pathway inhibitor response in cancer. Front. Oncol. 2012, 2, 109, doi: 10.3389/fonc.2012.00109.
34. Efferth, T., Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules. Curr. Med. Chem. 2012, 19, 5735-5744.
35. Kalra, N., Bhui, K., Roy, P., Srivastava, S. et al., Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol. Appl. Pharmacol. 2008, 226, 30-37.
36. Mynott, T. L., Ladhams, A., Scarmato, P., Engwerda, C. R., Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J. Immunol. 1999, 163, 2568-2575.
37. Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S. et al., Oxidative stress and antioxidant defense. World Allergy Organ. J. 2012, 5, 9-19.
38. Zavadova, E., Desser, L., Mohr, T., Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation. Cancer Biother. 1995, 10, 147-152.
39. Hale, L. P., Haynes, B. F., Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J. Immunol. 1992, 149, 3809-3816.
40. Cooper, K., Squires, H., Carroll, C., Papaioannou, D. et al., Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol. Assess. 2010, 14, 1-206.
41. Chobotova, K., Vernallis, A. B., Majid, F. A., Bromelain's activity and potential as an anti-cancer agent: current evidence and perspectives. Cancer Lett. 2010, 290, 148-156.